This Article Full Text Full Text (PDF) All Versions of this Article: 51/4/862    most recent HYPERTENSIONAHA.107.103127v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van den Born, B.-J. H. Articles by van Montfrans, G. A. Search for Related Content PubMed PubMed Citation Articles by van den Born, B.-J. H. Articles by van Montfrans, G. A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Genetics Home Reference Related Collections Coagulation

(Hypertension. 2008;51:862.)
© 2008 American Heart Association, Inc.

Original Articles

Association Between Thrombotic Microangiopathy and Reduced ADAMTS13 Activity in Malignant Hypertension

Bert-Jan H. van den Born; Niels V. van der Hoeven; Evelyn Groot; Peter J. Lenting; Joost C.M. Meijers; Marcel Levi; Gert A. van Montfrans

From the Departments of Internal and Vascular Medicine (B.-J.H.v.d.B., N.V.v.d.H., J.C.M.M., M.L., G.A.v.M.), Academic Medical Centre, Amsterdam, The Netherlands; and the Laboratory for Thrombosis and Hemostasis (E.G., P.J.L.), Department of Clinical Chemistry and Haematology, University Medical Centre Utrecht, Utrecht, The Netherlands.

Correspondence to Bert-Jan H. van den Born, Department of Internal and Vascular Medicine, Academic Medical Centre, Meibergdreef 9, Room F4-222, PO Box 22660, 1100 DD, Amsterdam, the Netherlands. E-mail b.j.vandenborn{at}amc.uva.nl

The thrombotic microangiopathy observed in malignant hypertension is similar to that of thrombotic thrombocytopenic purpura, which is associated with a deficiency of ADAMTS13, a von Willebrand factor (VWF)–cleaving protease that cleaves large prothrombogenic multimers. We hypothesized that ADAMTS13 is deficient in malignant hypertension and that the severity of thrombotic microangiopathy is associated with decreased ADAMTS13 activity. We included 20 patients with malignant and 20 patients with severe hypertension, and 20 matched normotensive individuals served as control subjects. VWF, active VWF, and free hemoglobin were assessed to explore predictors of ADAMTS13 activity. Patients with malignant hypertension had lower ADAMTS13 activity (80%; interquartile range: 53% to 130%) compared with control subjects (99% interquartile range: 82% to 129%; P<0.01) but not compared with patients with severe hypertension (P=0.14). ADAMTS13 activity negatively correlated with lactic dehydrogenase levels after logarithmic transformation (r=–0.65; P<0.001) and was associated with platelet count (r=0.34; P=0.04) and the presence of schistocytes (r=–0.37; P=0.02). Apart from the association with thrombotic microangiopathy, ADAMTS13 was inversely associated with creatinine (r=–0.42; P=0.008). Increasing levels of VWF were associated with a decrease in ADAMTS13 activity (r=–0.34; P=0.03). There was no significant association between ADAMTS13 activity and other parameters, including blood pressure. In conclusion, ADAMTS13 is decreased in malignant hypertension and associated with the severity of thrombotic microangiopathy, likely because of the release of VWF after endothelium stimulation. A severe deficiency could not be demonstrated. More studies are needed to identify the role of ADAMTS13 in the thrombotic microangiopathy and ischemic complications of malignant hypertension.

Key Words: hypertensive crisis • thrombotic microangiopathy • coagulation • kidney failure • endothelium

This article has been cited by other articles:

				X. Li, W. Zhang, H. Ren, X. Pan, and N. Chen Malignant hypertension complicated by acute renal failure BMJ Case Reports, June 14, 2009; 2009(jun11_2): bcr1020081116 - bcr1020081116. [Abstract] [Full Text]

				B.-J. H. van den Born and G. A. van Montfrans Response to the Malignant Hypertension-Thrombotic Microangiopathy Link Hypertension, October 1, 2008; 52(4): e33 - e33. [Full Text] [PDF]

				J. Thachil The Malignant Hypertension-Thrombotic Microangiopathy Link Hypertension, October 1, 2008; 52(4): e32 - e32. [Full Text] [PDF]